Jaguar Health
JAGX
6 hedge funds and large institutions have $229K invested in Jaguar Health in 2023 Q1 according to their latest regulatory filings, with 6 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
0% more ownership
Funds ownership: 0% → 0% (+0%)
54% less capital invested
Capital invested by funds: $503K → $229K (-$274K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
+$332K |
| 2 |
Acadian Asset Management
Boston,
Massachusetts
|
+$166K |
| 3 |
BlackRock
New York
|
+$166K |
| 4 |
Morgan Stanley
New York
|
+$166K |
| 5 |
Prudential Financial
Newark,
New Jersey
|
+$166K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
-$87.1K |
| 2 |
Renaissance Technologies
New York
|
-$82K |
| 3 |
Geode Capital Management
Boston,
Massachusetts
|
-$35K |
| 4 |
Bank of New York Mellon
New York
|
-$14.6K |
| 5 |
State Street
Boston,
Massachusetts
|
-$12.2K |
JAGX Hedge Fund Activity: Q1 2023 in Review
6 of the 6,275 institutional investors tracked by Wall St. Rank reported a position in Jaguar Health (JAGX) for Q1 2023, worth a combined $229K — down 54% from $503K a quarter earlier.
Buyers outnumbered sellers: 6 funds opened new JAGX positions and 0 closed out — a net gain of 6 holders — while 0 added to existing stakes and 0 trimmed.
The largest buyer was Vanguard Group, opening a new position worth an estimated $332K. The largest seller was Citadel Advisors, cutting an estimated $87.1K.
- 6 institutional investors held Jaguar Health (JAGX) as of Q1 2023, up from 0 in Q4 2022.
- Funds reported $229K of Jaguar Health stock for Q1 2023, down 54% quarter-over-quarter.
- 6 funds opened new Jaguar Health positions in Q1 2023 and 0 closed out, a net change of +6 holders.
- The largest Jaguar Health buyer in Q1 2023 was Vanguard Group, an estimated $332K added.
- The largest Jaguar Health seller in Q1 2023 was Citadel Advisors, an estimated $87.1K sold.
Based on aggregated 13F filings for Q1 2023.